This pioneering technology, used in only seven countries globally, will capture high-quality ultrasound images of the hand and wrist joints. These images will aid the Rheumatology department in assessing, monitoring, and guiding patient treatment.
The investment is expected to increase patient capacity and expedite scan times. By taking on imaging tasks, ARTHUR will also allow clinical staff to dedicate more time to patients with complex needs.
Patients with Rheumatoid Arthritis (RA) require frequent imaging, with the department currently performing 200 Hand MRIs annually and observing a consistent year-on-year increase in demand.
“"This investment is about using technology to deliver real improvements for our patients and colleagues. It means we can get to patients earlier and make interventions that add years to life and life to years."
“"ARTHUR allows earlier diagnosis which is very important as joint damage can occur if treatment is delayed. It will also help ease the burden on other services in the Trust like radiology and MRI where colleagues are managing huge demand."
The introduction of ARTHUR supports the Trust’s commitment to digital transformation and patient-centred care. It aligns with wider efforts to invest in technology that improves patient experiences and outcomes, while supporting staff efficiency. This includes recent investments in new pharmacy dispensing robots and AI work for faster stroke diagnosis.
